Your doctor smiles and says, "Everything looks normal." You walk out relieved, clutching a printout of numbers that supposedly confirm your health.
But something feels off.
You're exhausted despite eight hours of sleep. Your weight refuses to budge despite "doing everything right." Brain fog clouds your afternoons. And every time you look at your daughters, that whisper returns: Am I next?
But your doctor failed to share some very important information: those "normal" lab results aren't designed to catch disease early. They're designed to confirm it after the fact.
For women navigating perimenopause, managing family cancer history, or experiencing metabolic symptoms that doctors dismiss, this distinction is critical.
Standard lab ranges are based on population averages, not optimal health. When your doctor says your levels are "normal," what they mean is: you fall somewhere within the range that includes millions of Americans—many of whom are already developing disease but haven't crossed the threshold into diagnosis yet.
Let me show you what I mean.
Fasting glucose is considered "normal" up to 99 mg/dL. But research reveals that insulin resistance—the metabolic dysfunction that increases cancer risk—typically begins years before glucose rises. By the time your fasting glucose hits that "normal" upper limit, you've likely been metabolically compromised for years, quietly accumulating the exact terrain conditions where cancer thrives.
TSH (thyroid stimulating hormone) has a "normal" range of 0.5-5.0 mIU/L. But optimal thyroid function for most women—the kind that supports robust metabolism, cellular repair, and cancer surveillance—sits between 1.0-2.0 mIU/L. When your TSH creeps toward 3.0 or higher, your cells can't effectively repair DNA damage, your metabolism slows, and your immune system's ability to detect abnormal cells weakens. All "normal." All problematic.
Vitamin D is considered "sufficient" at 30 ng/mL. Yet research published in Annals of Epidemiology shows that cancer prevention requires levels between 50-80 ng/mL. At 30 ng/mL, you're deficient for the purpose of reducing cancer risk—your immune function, cellular differentiation, and inflammation control are all compromised. But your doctor checked a box marked "sufficient" and moved on.
This is the gap that keeps women stuck, confused, and at risk.
When we shift from detecting disease to preventing it, we need different information. These are the metabolic markers that reveal early dysfunction—the kind your body has been signaling through fatigue, weight gain, inflammation, and hormonal chaos.
This is the single most important marker for disease risk that most doctors never order.
Elevated insulin doesn't just drive weight gain and fatigue—it fuels cancer development. Cancer cells have 10-20 times more insulin receptors than normal cells. When insulin stays chronically elevated, you're literally feeding the exact cellular environment where cancer thrives, as detailed by Gallagher and LeRoith in Physiological Reviews.
Your fasting glucose can look perfect while insulin is screaming for help. This is insulin resistance in its early stages—your body pumping out more insulin to keep blood sugar stable, exhausting your metabolism and creating inflammation in the process.
Optimal range: 2-7 μIU/mL
What most labs consider "normal": Up to 25 μIU/mL
See the problem?
While fasting glucose gives you a snapshot, Hemoglobin A1c reveals your three-month average blood sugar levels. This marker catches the roller coaster that single fasting tests miss—the post-meal spikes, the midnight crashes, the metabolic chaos happening behind the scenes.
Optimal range: Below 5%
Standard "normal": Below 5.7%
That 0.7% difference matters. When A1c rises above 5%, you're in prediabetic territory metabolically, even though your doctor won't flag it for years.
This measures systemic inflammation—the silent fire that drives cancer development. Chronic inflammation damages DNA, suppresses immune surveillance, and promotes the blood vessel formation that feeds tumors.
When inflammation stays elevated, you're not just dealing with aches and brain fog. You're creating the exact terrain conditions where cancer cells can evade detection and thrive.
Optimal range: Below 1.0 mg/L
Standard "normal": Below 3.0 mg/L
This isn't just about bone health. Vitamin D regulates over 200 genes involved in cellular differentiation, immune function, and inflammation control. Research from Garland and colleagues in Annals of Epidemiology demonstrates that optimal vitamin D levels significantly reduce cancer risk across multiple cancer types.
When vitamin D drops below optimal levels, your immune system can't effectively identify and destroy abnormal cells. Your body's natural cancer surveillance weakens.
Optimal range: 50-80 ng/mL
Standard "sufficient": 30 ng/mL
Most doctors test TSH alone. That's like trying to understand a conversation by hearing only one word.
A complete thyroid panel includes TSH, Free T3, Free T4, Reverse T3, and thyroid antibodies. This reveals whether your thyroid is producing enough hormone, whether your body is converting it to the active form (T3), whether stress is shunting it into the inactive form (Reverse T3), and whether autoimmune processes are attacking your thyroid.
When thyroid function is suboptimal, your metabolism slows, DNA repair mechanisms falter, and cellular cleanup processes become sluggish. The connection to cancer risk is direct: your cells can't effectively remove damaged components or repair genetic errors.
Elevated homocysteine indicates problems with methylation—the biochemical process that controls DNA repair, detoxification, and gene expression. When methylation falters, your body struggles to repair DNA damage and eliminate carcinogenic compounds.
This marker reveals how well your body is handling its cellular maintenance and cleanup processes.
Optimal range: Below 7 μmol/L
Standard "normal": Below 15 μmol/L
IGF-1 promotes cellular growth and division. While necessary for normal tissue repair, chronically elevated IGF-1 can promote cancer cell proliferation. This marker needs careful interpretation based on age and context, but tracking it matters for women with cancer risk.
Optimal range: 100-200 ng/mL (varies by age)
These markers tell a story about your metabolic terrain—the internal environment that determines whether your body creates resilience or vulnerability to disease.
When your doctor says your labs are "normal" but you feel far from well, trust your body. Those symptoms—the fatigue, the weight gain, the inflammation, the hormonal chaos—aren't in your head. They're your body's warning system, signaling that your terrain needs attention before those "normal" labs cross into disease territory.
This is why conventional medicine so often fails women navigating perimenopause, managing family cancer history, or experiencing early metabolic dysfunction. Standard testing wasn't designed to catch the warning signs. It was designed to diagnose disease after it develops.
But you don't have to wait for a diagnosis. You can address metabolic dysfunction now, while there's still time to change the trajectory.
Bring this list to your next appointment. Ask for these specific tests. If your doctor dismisses your concerns or insists "everything is fine" based on standard panels, you need a practitioner who understands functional ranges and early intervention.
Finding someone who will order these tests, interpret them through the lens of optimal function rather than disease diagnosis, and help you address imbalances before they spiral—that's the difference between catching disease and preventing it.
Ready to understand your metabolic terrain and take control of your cancer risk? Book a From Fear to Freedom Metabolic Assessment Call, or explore The Visconti Method—a comprehensive program designed to address the root metabolic drivers of disease before they progress.
Gallagher, E. J., & LeRoith, D. (2015). Obesity and diabetes: The increased risk of cancer and cancer-related mortality. Physiological Reviews, 95(3), 727-748.
Garland, C. F., Gorham, E. D., Mohr, S. B., & Garland, F. C. (2011). Vitamin D for cancer prevention: Global perspective. Annals of Epidemiology, 21(7), 468-474.
Download The Terrain Reset Guide | Book Your Assessment Call
